rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-7-14
|
pubmed:abstractText |
Although angiotensin receptor antagonists and 3-hydroxy-3-methylgultaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have been shown to attenuate proteinuria individually, it remains unclear whether proteinuria may be additionally improved by statin therapy in well-controlled hypertensive patients treated with angiotensin receptor antagonists-based regimen and whether withdrawal of chronic statin treatment may abrogate this beneficial effect in normolipidemic patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0085-2538
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
779-87
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16014056-Adult,
pubmed-meshheading:16014056-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:16014056-Drug Interactions,
pubmed-meshheading:16014056-Drug Resistance,
pubmed-meshheading:16014056-Endothelin-1,
pubmed-meshheading:16014056-Female,
pubmed-meshheading:16014056-Humans,
pubmed-meshheading:16014056-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:16014056-Hypertension, Renal,
pubmed-meshheading:16014056-Lipids,
pubmed-meshheading:16014056-Losartan,
pubmed-meshheading:16014056-Male,
pubmed-meshheading:16014056-Middle Aged,
pubmed-meshheading:16014056-Pravastatin,
pubmed-meshheading:16014056-Proteinuria,
pubmed-meshheading:16014056-Substance Withdrawal Syndrome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT receptor blockers.
|
pubmed:affiliation |
Cardiology Section, Department of Internal Medicine, Taipei Medical University and Chi-Mei Medical Center, Tainan, Taiwan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|